1
|
Gnangnon FHR, Lawani I, Knight SR, Parenté A, Dossou FM, Totah T, Houinato DS, Blanquet V, Preux PM, Harrison EM. Assessing the continuum of care in Sub-Saharan African hospitals performing surgery for breast cancer: a secondary analysis of the GlobalSurg 3 study. BMC Cancer 2024; 24:1529. [PMID: 39695461 DOI: 10.1186/s12885-024-13267-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2023] [Accepted: 11/27/2024] [Indexed: 12/20/2024] Open
Abstract
BACKGROUND While breast cancer incidence rates in Sub-Saharan Africa (SSA) are among the lowest worldwide, mortality rates remain among the highest, reflecting particularly poor survival. Only a few studies in SSA have investigated the capabilities of treatment services to adequately provide a continuum of care for breast cancer. Our aim was to assess the availability of diagnostic facilities and adjuvant therapies in hospitals performing breast cancer surgery in SSA. METHODS We performed a secondary analysis of the GlobalSurg3 study data collected in the SSA region. The GlobalSurg 3 study is a multicenter, international, prospective, observational study of hospitals providing surgical services for cancer patients (including breast cancer) around the world. A total of 47 hospitals from 15 SSA countries and 43 cities were included between April 1, 2018, and Jan 31, 2019. RESULTS One-third of hospitals covered a population greater than two million (n = 17; 36.2%). Ultrasound was available in all hospitals; however, it was not consistently functional in 11 hospitals (23.4%). Only half of the included hospitals (n = 26, 55.3%) had access to a full-time pathologist, whilst the multidisciplinary team (MDT) approach was absent in 42.4% of hospitals. Radiotherapy equipment was only available in nine hospitals (19.1%). Only half of the hospitals (n = 25, 53.1%) had chemotherapy drugs available on site. In nine hospitals (19.1%), patients had to travel more than 50 km to access chemotherapy drugs. CONCLUSIONS Outcomes for breast cancer patients in SSA cannot be improved without significant investments in pathology, surgical and oncological treatment pathways to provide timely diagnostic and effective treatment.
Collapse
Affiliation(s)
- Freddy Houéhanou Rodrigue Gnangnon
- Laboratory of Epidemiology of Chronic and Neurological Diseases, University of Abomey-Calavi, Cotonou, Benin.
- Department of Visceral Surgery, National Teaching Hospital-Hubert Koutoukou Maga, CNHU-HKM, Cotonou, Benin.
- Institute of Epidemiology and Tropical Neurology, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, OmegaHealth, 3Inserm U1094, IRD UMR270, Limoges, France.
| | - Ismaïl Lawani
- University and Departmental Hospital Oueme-Plateau, Porto-Novo, Benin
- NIHR Global Health Research Unit on Global Surgery, Cotonou, Benin
| | - Stephen R Knight
- Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK
| | - Alexis Parenté
- Laboratory of Epidemiology of Chronic and Neurological Diseases, University of Abomey-Calavi, Cotonou, Benin
- Institute of Epidemiology and Tropical Neurology, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, OmegaHealth, 3Inserm U1094, IRD UMR270, Limoges, France
| | | | - Terrence Totah
- Laboratory of Epidemiology of Chronic and Neurological Diseases, University of Abomey-Calavi, Cotonou, Benin
| | - Dismand Stephan Houinato
- Laboratory of Epidemiology of Chronic and Neurological Diseases, University of Abomey-Calavi, Cotonou, Benin
- Institute of Epidemiology and Tropical Neurology, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, OmegaHealth, 3Inserm U1094, IRD UMR270, Limoges, France
| | - Véronique Blanquet
- Institute of Epidemiology and Tropical Neurology, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, OmegaHealth, 3Inserm U1094, IRD UMR270, Limoges, France
| | - Pierre-Marie Preux
- Institute of Epidemiology and Tropical Neurology, Univ. Limoges, CHU Limoges, EpiMaCT - Epidemiology of Chronic Diseases in Tropical Zone, OmegaHealth, 3Inserm U1094, IRD UMR270, Limoges, France
| | - Ewen M Harrison
- Centre for Medical Informatics, Usher Institute, University of Edinburgh, Edinburgh, UK
| |
Collapse
|
2
|
Manson EN, Hasford F, Trauernicht C, Ige TA, Inkoom S, Inyang S, Samba O, Khelassi-Toutaoui N, Lazarus G, Sosu EK, Pokoo-Aikins M, Stoeva M. Africa's readiness for artificial intelligence in clinical radiotherapy delivery: Medical physicists to lead the way. Phys Med 2023; 113:102653. [PMID: 37586146 DOI: 10.1016/j.ejmp.2023.102653] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/12/2023] [Revised: 07/30/2023] [Accepted: 08/05/2023] [Indexed: 08/18/2023] Open
Abstract
BACKGROUND There have been several proposals by researchers for the introduction of Artificial Intelligence (AI) technology due to its promising role in radiotherapy practice. However, prior to the introduction of the technology, there are certain general recommendations that must be achieved. Also, the current challenges of AI must be addressed. In this review, we assess how Africa is prepared for the integration of AI technology into radiotherapy service delivery. METHODS To assess the readiness of Africa for integration of AI in radiotherapy services delivery, a narrative review of the available literature from PubMed, Science Direct, Google Scholar, and Scopus was conducted in the English language using search terms such as Artificial Intelligence, Radiotherapy in Africa, Machine Learning, Deep Learning, and Quality Assurance. RESULTS We identified a number of issues that could limit the successful integration of AI technology into radiotherapy practice. The major issues include insufficient data for training and validation of AI models, lack of educational curriculum for AI radiotherapy-related courses, no/limited AI teaching professionals, funding, and lack of AI technology and resources. Solutions identified to facilitate smooth implementation of the technology into radiotherapy practices within the region include: creating an accessible national data bank, integrating AI radiotherapy training programs into Africa's educational curriculum, investing in AI technology and resources such as electronic health records and cloud storage, and creation of legal laws and policies to support the use of the technology. These identified solutions need to be implemented on the background of creating awareness among health workers within the radiotherapy space. CONCLUSION The challenges identified in this review are common among all the geographical regions in the African continent. Therefore, all institutions offering radiotherapy education and training programs, management of the medical centers for radiotherapy and oncology, national and regional professional bodies for medical physics, ministries of health, governments, and relevant stakeholders must take keen interest and work together to achieve this goal.
Collapse
Affiliation(s)
| | | | | | | | | | | | - Odette Samba
- General Hospital of Yaoundé and University of Yaoundé I, Cameroon.
| | | | - Graeme Lazarus
- Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
| | - Edem Kwabla Sosu
- School of Nuclear and Allied Sciences, University of Ghana, Ghana.
| | | | | |
Collapse
|
3
|
Lombe D, M'ule BC, Msadabwe SC, Chanda E. Gynecological radiation oncology in sub-Saharan Africa: status, problems and considerations for the future. Int J Gynecol Cancer 2022; 32:451-456. [PMID: 35256436 DOI: 10.1136/ijgc-2021-002461] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Accepted: 12/16/2021] [Indexed: 11/04/2022] Open
Abstract
Gynecological malignancies in Africa form a significant part of the burden of disease. The high prevalence of HIV in some countries creates a heightened risk for development of human papilloma virus related cancers such as cervical, vulval and vaginal cancers. Radiotherapy is an important modality of treatment for cancer and in Africa compensates for the lack of adequate surgical services for a large proportion of cancers as well as being a cornerstone of treatment for locally advanced cancers and palliation. In this review we look at the status of radiotherapy services in sub-Saharan Africa and critical factors that influence its delivery with a focus on gynecological malignancies. This unveils that radiotherapy for gynecological cancers in sub-Saharan Africa is a significant example of the need for a holistic development approach across different sectors of the economy and different disciplines of medicine. The complexity of its management continues to expose the underdevelopment of health and financial systems and the lack of universal health coverage and social systems as we continue to see unnecessary morbidity and mortality due to the lack of organization. More systematic and scientifically robust investigations tailored to the various sub-Saharan Africa countries need to be conducted to elicit disruptive local solutions to the status quo.
Collapse
Affiliation(s)
- Dorothy Lombe
- Regional Cancer Treatment Services, MidCentral District Health Board, Palmerston North, New Zealand
| | | | - Susan C Msadabwe
- Department of Oncology, Cancer Diseases Hospital, Lusaka, Zambia
| | - Ernest Chanda
- Radiation Therapy, Cancer Diseases Hospital, Lusaka, Zambia
| |
Collapse
|